Gilead Sciences Commits to Veeva Vault CRM
Get Alerts VEEV Hot Sheet
Join SI Premium – FREE
Next generation CRM with deep capabilities and agentic AI
"Gilead is a leader in life changing medicines and has been a pioneer of major scientific advancements in virology, inflammation, and oncology," said Veeva CEO
"We are excited to expand our long-standing partnership with Veeva by moving to Vault CRM," said Anna Åsberg, global CIO at Gilead Sciences. "We share a deep commitment to advancing medicine and are excited to explore the potential of Veeva AI to help drive commercial execution to the next level."
Vault CRM is part of the Vault CRM Suite of applications that provides the foundation for commercial execution. Veeva AI for Vault CRM delivers multiple AI agents, including pre-call planning, compliant free text, and voice control, to drive commercial efficiency and effectiveness.
About Veeva Systems
Veeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. Gilead operates in more than 35 countries worldwide, with headquarters in
Veeva Forward-Looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended
Contact:
Veeva Systems
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/gilead-sciences-commits-to-veeva-vault-crm-302551872.html
SOURCE Veeva Systems
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vireo Growth completes $20M Pennsylvania dispensary license deal
- Kalaris reports positive TH103 Phase 1a data in neovascular AMD
- Leifras wins school club contract covering Itoshima City's junior highs
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share